The director shall grant a variance to a basic ambulance service licensee to carry and to administer beta agonist with or without an anticholinergic by metered dosed inhalation or nebulization, or both; premeasured epinephrine by intranasal or intramuscular route; sublingual nitroglycerin; or premeasured intramuscular, intranasal, or subcutaneous glucagon only if the licensee shows that:
each attendant who will administer the drug has satisfactorily completed training in the administration of the drug and the training has been approved by the licensee's medical director;
the licensee's medical director has developed or approved standing orders for the use of the drug;
continuing education or clinical training in the administration of the drug shall be provided at least annually to the licensee's attendants who are trained to administer the drug; and
at all times, at least one attendant on duty is trained in accordance with item A to administer the drug for which the ambulance service has been granted a variance.
Documentation of items A to E must be retained in the licensee's files.
In order to maintain a variance granted under subpart 7, the licensee's medical director shall, by the annual anniversary date of the approved variance:
certify in writing that each attendant has satisfactorily completed the required training and retained skill proficiency; and
certify in writing that, prior to allowing an attendant who was hired after the variance was granted to administer a drug specified in subpart 7, the attendant satisfactorily completed the required training under subpart 7, item A.
Documentation of items A to C shall be retained in the licensee's files.
A basic ambulance service shall not be granted a variance for the establishment of intravenous therapy involving the use of drugs other than solutions for intravenous infusion.
L 1987 c 209 s 39; 14 SR 519; L 1996 c 324 s 6; 22 SR 1877; L 1999 c 245 art 9 s 66; 50 SR 165
August 27, 2025
Official Publication of the State of Minnesota
Revisor of Statutes